Notably, FcγRIIIA/CD16A activation levels in patients with critical disease were comparable to those measured in SLE patients, where circulating sICs are established to crucially contribute to tissue damage and disease manifestations80,81. Here, FCGR3A is linked to systemic lupus erythematosus.